Biodistribution and tumor uptake of C60(OH) x in mice
Source abstract
Abstract
Radiolabeling of fullerol, 125I–C60(OH) x , was performed by the traditional chloramine-T method. The C–I covalent bond in I–C60(OH) x was characterized by X-ray photoelectron spectroscopy (XPS) that was sufficiently stable for in vivo study. Laser light scattering spectroscopy clearly showed that C60(OH) x aggregated to large nanoparticle clumps with a wide range of distribution. The clumps formed were also visualized by transmission electron microscope (TEM). We examined the biodistribution and tumor uptake of C60(OH) x in five mouse bearing tumor models, including mouse H22 hepatocarcinoma, human lung giantcellcarcinoma PD, human colon cancer HCT-8, human gastric cancer MGC803, and human OS732 osteosarcoma. The accumulation ratios of 125I–C60(OH) x in mouse H22 hepatocarcinoma to that in normal muscle tissue (T/N) and blood (T/B) at 1, 6, 24 and 72 h, reveal that 125I–C60(OH) x gradually accumulates in H22 tumor, and retains for a quite long period (e.g., T/N 3.41, T/B 3.94 at 24 h). For the other four tumor models, the T/N ratio at 24 h ranges within 1.21–6.26, while the T/B ratio ranges between 1.23 and 4.73. The accumulation of C60(OH) x in tumor is mostly due to the enhanced permeability and retention effect (EPR) and the phagocytosis of mononuclear phagocytes. Hence, C60(OH) x might serve as a photosensitizer in the photodynamic therapy of some kinds of tumor.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Fullerene Chemistry and Applications · Diamond and Carbon-based Materials Research · Polymer Nanocomposite Synthesis and Irradiation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (28)
Show source-provided references
1. Bernstein R., Prat F., Foote C.S. (1999) On the mechanism of DNA cleavage by fullerenes investigated in model systems: electron transfer from guanosine and 8-oxo-guanosine derivatives to C60. J. Am. Chem. Soc. 121: 464–46510.1021/ja983335d ↗
2. Bianco A., Maggini M., Scorrano G., Toniolo C., Marconi G., Villani C., Prato M. (1996) Synthesis, chiroptical properties, and configurational assignment of fulleroproline derivatives and peptides. J. Am. Chem. Soc. 118: 4072–408010.1021/ja9539249 ↗
3. Brettreich M., Hirsch A. (1998) A highly water-soluble dendro[60]fullerene. Tetrahedron Lett. 39: 2731–273410.1016/S0040-4039(98)00491-2 ↗
4. Brigger I., Dubernet C., Couvreur P. (2002) Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliver. Rev. 54: 631–65110.1016/S0169-409X(02)00044-3 ↗
5. Bullard-Dillard R., Creek K.E., Scrivens W.A., Tour J.M. (1996) Tissue sites of uptake of 14C-labeled C60. Bioorg. Chem. 24: 376–38510.1006/bioo.1996.0032 ↗
6. Burley, G.A., Keller, P.A., Pyne, S.G. & G.E. Ball, 1998. Synthesis of a 1,2-dihydro[60]fullerylglycine derivative by a novel cyclopropane ring opening of a methano[60]fullerene. Chem. Commun., 2539–254010.1039/a806865h ↗
7. Cagle D.W., Kennel S.J., Mirzadeh S., Alford J.M., Wilson L.J. (1999) In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers. Proc. Natl. Acad. Sci. USA 96: 5182–518710.1073/pnas.96.9.5182 ↗
8. Chen Y., Cai R.F., Chen S.M., Huang Z.E. (2001) Synthesis and characterization of fullerol derived from C60(n−) precursors. J. Phys. Chem. Solids 62: 999–100110.1016/S0022-3697(00)00242-0 ↗
9. Cusan, C., Da Ros, T. Spalluto, G., Foley, S., Janot, J.M., Seta, P., Larroque, C., Tomasini, M.C., Antonelli, T., Ferraro, L. & M. Prato, 2002. A new multi-charged C60 derivative: synthesis and biological properties. Eur. J. Org. Chem., 2928–293410.1002/1099-0690(200209)2002:17<2928::AID-EJOC2928>3.0.CO;2-I ↗
10. Dugan L.L., Gabrielsen J.K., Yu S.P., Lin T.S., Choi D.W. (1996) Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol. Dis. 3: 129–13510.1006/nbdi.1996.0013 ↗
11. Friedman S.H., DeCamp D.L., Sijbesma R.P., Srdanov G., Wudl F., Kenyon G.L. (1993) Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification. J. Am. Chem. Soc. 115: 6506–650910.1021/ja00068a005 ↗
12. Guldi D.M., Asmus K.D. (1999) Activity of water-soluble fullerenes towards (OH)-O-center dot-radicals and molecular oxygen. Radiat. Phys. Chem. 56: 449–45610.1016/S0969-806X(99)00325-4 ↗
13. Hirsch A., Lamparth I., Grösser T. (1994) Regiochemistry of multiple additions to the fullerene core: Synthesis of a th-symmetric hexakis adduct of C60 with bis(ethoxycarbonyl)methylene. J. Am. Chem. Soc. 116: 9385–938610.1021/ja00099a088 ↗
14. Hobbs S., Monsky W.L., Yuan F., Robersts W.G., Griffith L., Torchilin V.P., Jain R.K. (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenviroment. Proc. Natl. Acad. Sci. USA 95: 4607–461210.1073/pnas.95.8.4607 ↗
15. Hsu S.C., Wu C.C., Luh T.Y., Chou C.K., Han S.H., Lai M.Z. (1998) Apoptotic signal of Fas is not mediated by ceramide. Blood 91: 2658–266310.1182/blood.V91.8.2658.2658_2658_2663 ↗
16. Kim S.H., Son H., Nam G., Chi D.Y., Kim J.H. (2000) Synthesis and in vitro antibacterial activity of 3-[N-methyl-N-(3-methyl-1,3-thiazolium-2-yl)amino]methyl cephalosporin derivatives. Bioorg. Med. Chem. Lett. 10: 1143–114510.1016/S0960-894X(00)00130-X ↗
17. Krätschemer W., Lamb L.D., Fostiropoulos K., Huffman (1990) Solid C60: a new form of carbon. Nature 347: 354–35810.1038/347354a0 ↗
18. Krstic J.S. (1997) Effects of C60(OH)24 on microtubule assembly. Arch. Oncol. 5: 143–147
19. Li, J., Takeuchi, A., Ozawa, M., Li, X.H., Saigo, K. & K. Kitazawa, 1993. C60 fullerol formation catalyzed by quaternary ammonium hydroxides. J. Chem. Soc. Chem. Commun., 1784–178510.1039/c39930001784 ↗
20. Li Q.N., Xiu Y., Zhang X.D., Liu R.L., Du Q.Q., Shun X.Q., Chen S.L., Li W.X. (2002) Preparation of 99 mTc-C60(OH)x and its biodistribution studies. Nucl. Med. Biol. 29: 707–71010.1016/S0969-8051(02)00313-X ↗
21. Maeda H. (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41: 189–20710.1016/S0065-2571(00)00013-3 ↗
22. Matsumura Y., Maeda H. (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46: 6387–6392
23. Satoh M., Matsuo K., Kiriya H., Mashino T., Nagano T., Hirobe M., Takayanagi I. (1997) Inhibitory effects of a fullerene derivative, dimalonic acid C60, on nitric oxide-induced relaxation of rabbit aorta. Eur. J. Pharmacol. 327: 175–18110.1016/S0014-2999(97)89658-6 ↗
24. Tabata Y., Ikada Y. (1999) Biological functions of fullerene. Pure & Appl. Chem. 71: 2047–205310.1351/pac199971112047 ↗
25. Tokuyama H., Yamago S., Nakamura E., Shiraki T., Sugiura Y. (1993) Photoinduced biochemical activity of fullerene carboxylic acid. J. Am. Chem. Soc. 115: 7918–791910.1021/ja00070a064 ↗
26. Ueng T.H., Kang J.J., Wang H.W., Cheng Y.W., Chiang L.Y. (1997) Suppression of microsomal cytochrome P450-dependent monooxygenases and mitochondrial oxidative phosphorylation by fullerenol, a polyhydroxylated fullerene C60. Toxicol. Lett. 93: 29–3710.1016/S0378-4274(97)00071-4 ↗
27. Wang I.C., Tai L.A., Lee D.D., Kanakamma P.P., Shen C.K.F., Luh T.Y., Chen C.H., Hwang K.C. (1999) C60 and water-soluble fullerene derivatives as antioxidants against radical-initiated lipid peroxidation. J. Med. Chem. 42: 4614–462010.1021/jm990144s ↗
28. Wang H.F., Wang J., Deng X.Y., Sun H.F., Shi Z.J., Gu Z.N., Liu Y.F., Zhao Y.L. (2004) Biodistribution of carbon single-wall nanotubes in mice. J. Nanosci. Nanotech. 4(8): 1–6